Table 1.
Variable | Insomnia Score Level (WHIIRS)a |
P Valueb | |||||||
---|---|---|---|---|---|---|---|---|---|
0–3 (n = 39,607) |
4–6 (n = 39,227) |
7–10 (n = 36,427) |
≥11 (n = 27,622) |
||||||
% | Mean | % | Mean | % | Mean | % | Mean | ||
Age at baseline, years | 62.5 | 63.1 | 63.4 | 63.3 | <0.0001 | ||||
Ethnicity, white non-Hispanic | 81.3 | 83.0 | 84.8 | 82.9 | <0.0001 | ||||
Education, college graduate or above | 44.2 | 40.5 | 38.4 | 32.0 | <0.0001 | ||||
Body mass indexc | 27.6 | 28.0 | 28.0 | 28.4 | <0.0001 | ||||
Physical activity, METs/week | 13.7 | 12.5 | 11.9 | 11.3 | <0.0001 | ||||
Smoking status | <0.0001 | ||||||||
Never smokers | 52.3 | 50.7 | 49.7 | 49.4 | |||||
Former smokers | 39.3 | 41.5 | 42.8 | 42.2 | |||||
Current smokers | 29.8 | 26.1 | 23.5 | 20.5 | |||||
Alcohol intake, ≥7 drinks/week | 10.9 | 11.6 | 12.3 | 11.6 | <0.0001 | ||||
Family history of cancer | 44.6 | 46.7 | 47.5 | 48.0 | <0.0001 | ||||
Previous thyroid disease (yes) | 21.0 | 23.5 | 25.0 | 25.1 | <0.0001 | ||||
Hormone therapy use | <0.0001 | ||||||||
Estrogen alone | 27.4 | 29.2 | 30.9 | 32.4 | |||||
Estrogen plus progestin | 23.1 | 21.7 | 21.1 | 19.5 | |||||
Mixed use | 5.2 | 5.6 | 5.9 | 5.8 | |||||
Depression score (CES-D/DIS) | |||||||||
Mean score | 0.01 | 0.02 | 0.04 | 0.10 | <0.0001 | ||||
Score ≥0.06 | 10.3 | 17.5 | 28.2 | 44.0 | <0.0001 |
Abbreviations: CES-D, Center for Epidemiologic Studies Depression Scale; DIS, National Institute of Mental Health's Diagnostic Interview Schedule; METs, metabolic equivalents; WHIIRS, Women's Health Initiative Insomnia Rating Scale.
a Sleep disturbance level was classified into 4 categories (WHIIRS: 0–3, 4–6, 7–10, and ≥11). The cutpoints were “quasi-quartiles” based on distribution of the ordinal scale 0–20 from WHIIRS.
b P values were obtained from analysis of variance when the exposures were continuous and from chi-square tests when the exposures were categorical.
c Weight (kg) / height (m)2.